1. Home
  2. DNLI vs PAGS Comparison

DNLI vs PAGS Comparison

Compare DNLI & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • PAGS
  • Stock Information
  • Founded
  • DNLI 2013
  • PAGS 2006
  • Country
  • DNLI United States
  • PAGS Brazil
  • Employees
  • DNLI N/A
  • PAGS N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • PAGS EDP Services
  • Sector
  • DNLI Health Care
  • PAGS Technology
  • Exchange
  • DNLI Nasdaq
  • PAGS Nasdaq
  • Market Cap
  • DNLI 2.1B
  • PAGS 2.3B
  • IPO Year
  • DNLI 2017
  • PAGS N/A
  • Fundamental
  • Price
  • DNLI $15.43
  • PAGS $9.60
  • Analyst Decision
  • DNLI Strong Buy
  • PAGS Buy
  • Analyst Count
  • DNLI 15
  • PAGS 7
  • Target Price
  • DNLI $33.62
  • PAGS $11.36
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • PAGS 4.8M
  • Earning Date
  • DNLI 11-05-2025
  • PAGS 08-13-2025
  • Dividend Yield
  • DNLI N/A
  • PAGS 1.46%
  • EPS Growth
  • DNLI N/A
  • PAGS 20.55
  • EPS
  • DNLI N/A
  • PAGS 1.30
  • Revenue
  • DNLI N/A
  • PAGS $3,543,799,551.00
  • Revenue This Year
  • DNLI N/A
  • PAGS $19.16
  • Revenue Next Year
  • DNLI $802.87
  • PAGS $6.56
  • P/E Ratio
  • DNLI N/A
  • PAGS $7.14
  • Revenue Growth
  • DNLI N/A
  • PAGS 14.53
  • 52 Week Low
  • DNLI $10.57
  • PAGS $6.11
  • 52 Week High
  • DNLI $33.33
  • PAGS $10.21
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 56.61
  • PAGS 66.46
  • Support Level
  • DNLI $14.52
  • PAGS $8.93
  • Resistance Level
  • DNLI $16.20
  • PAGS $9.11
  • Average True Range (ATR)
  • DNLI 0.70
  • PAGS 0.29
  • MACD
  • DNLI -0.01
  • PAGS 0.09
  • Stochastic Oscillator
  • DNLI 62.44
  • PAGS 89.93

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

Share on Social Networks: